Late onset ulcerative colitis complicating a patient with Budd-Chiari syndrome: A case report and review of the literature

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 1, 2009, Pages 109-113

  Vassiliadis, Themistoklis ^a   Mpoumponaris, Alexander ^a,c   Giouleme, Olga ^a   Hatzidakis, Adam ^b   Patsiaoura, Kalliopi ^a   Zezos, Petros ^a   Vakalopoulou, Sofia ^a   Kargiotis, Konstantinos ^a   Gkisakis, Dimitrios ^a   Katsinelos, Panagiotis ^a   Evgenidis, Nikolaos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Hospital of Heraclion   (Greece)

^c NONE   (Greece)

Author keywords

Budd Chiari syndrome; Polycythemia vera; Ulcerative colitis

Indexed keywords

ALBUMIN; ASENOCUMAROL; CIPROFLOXACIN; FUROSEMIDE; MESALAZINE; PREDNISONE; PROKINETIC AGENT; PROPRANOLOL; SPIRONOLACTONE; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; BUDD CHIARI SYNDROME; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; DISEASE COURSE; DOPPLER FLOWMETRY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HUMAN TISSUE; LIVER FUNCTION TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADULT; ASCITES; BUDD-CHIARI SYNDROME; COLITIS, ULCERATIVE; FEMALE; HUMANS; POLYCYTHEMIA VERA;

EID: 58149214122     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32830263cb     Document Type: Article

References (35)

1. Attwell A, Ludkowski M, Nash R, Kugelmas M. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation. Aliment Pharmacol Ther 2004; 20:867-873.
2. Denninger MH, Chait Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000; 31:587-591.
3. Talbot RW, Heppell J, Dozois RR, Beart RW Jr. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986; 61:140-145.
4. Praderio L, Dagna L, Longhi P, Rubin G, Sabbadini MG. Budd-Chiari syndrome in a patient with ulcerative colitis: association with anticardiolipin antibodies. J Clin Gastroenterol 2000; 30:203-204.
5. Rahhal RM, Pashankar DS, Bishop WP. Ulcerative colitis complicated by ischemic colitis and Budd-Chiari syndrome. J Pediatr Gastroenterol Nutr 2005; 40:94-97.
6. Chesner IM, Muller S, Newman J. Ulcerative colitis complicated by Budd-Chiari syndrome. Gut 1986; 27:1096-1100.
7. Whiteford MH, Moritz MJ, Ferber A, Fry RD. Budd-Chiari syndrome complicating restorative proctocolectomy for ulcerative colitis: report of a case. Dis Colon Rectum 1999; 42:1220-1224.
8. Janssen H, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC. Budd-Chiari syndrome : a review by an expert panel. J Hepatol 2003; 38:364-371.
9. Mancuso A, Fung K, Mela M, Tibballs J, Watkinson A, Burroughs AK, Patch D. TIPS for acute and chronic Budd-Chiari syndrome: a single-center experience. J Hepatol 2003; 38:751-754.
10. Valla D. Hepatic vein thrombosis (Budd-Chiari syndrome). Semin Liver Dis 2002; 22:5-14.
11. Narayanan Menon KV, Shah V, Kamath P. The Budd-Chiari syndrome. N Engl J Med 2004; 350:578-585.
12. Valla D, Casadevall N, Lacombe C, Varet B, Goldwasser E, Franco D, et al. Primary myeloproliferative disorders and hepatic vein thrombosis: a prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med 1985; 103:329-334.
13. Patel R, Lea N, Heneghan M, Westwood NB, Milojkovic D, Thanigaikumar M, et al. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology 2006; 130:2031-2038.
14. Koutroubakis IE. Therapy insight: vascular complications in patients with inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol 2005; 6:266-272.
15. Miehsler W, Reinisch W, Valic E, Osterode W, Tillinger W, Feichtenschlager T, et al. Is inflammatory bowel disease an independent and disease specific factor for thromboembolism? Gut 2004; 53:542-548.
16. Gardiner KR, Barclay GR, McCaigue MD, Milne L, Brown D, Stephens S, et al. The significance of systemic endotoxinemia in inflammatory bowel disease. Gut 1995; 36:897-901.
17. Mudter J, Neurath MF. II-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis 2007; 13:1016-1023.
18. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 1989; 30:835-838.
19. Hommes D, Van Dullemen H, Levi M, Van der Ende A, Woody J, Tytgat GN, Van deventer SJ. Beneficial effect of treatment with a monoclonal anti-tumor necrosis factor-a antibody on markers of coagulation and fibrinolysis in patients with active Crohn's disease. Haemostasis 1997; 27:269-277.
20. Cybulsky M, Chan W, Movat H. Acute inflammation and microthrombosis induced by endotoxin, interleukin-1 and tumor necrosis factor and their implication in gram-negative infection. Lab Invest 1988; 58:365-378.
21. Feldstein VA, Patel MD, LaBerge JM. Transjugular intrahepatic portosystemic shunts: accuracy of Doppler US in determination of patency and detection of stenosis. Radiology 1996; 201:141-147.
22. Foshager MC, Ferrai H, Nazarran GK, Castañeda-Zúñiga WR, Letourneau JG. Duplex sonography after transjugular portsystemic shunts (TIPS): normal hemodynamic findings and efficacy in predicting shunt patency and stenosis. Am J Roentgenol 1995; 165:1-7.
23. Jalan R, Lui HF, Redhead DN, Hayes PC. TIPSS 10 years on. Gut 2000; 46:578-581.
24. Benito A, Bilbao J, Hernandez T, Martinez-Cuesta A, Larrache J, González I, Vivas I. Doppler ultrasound for TIPS: does it work? Abdom Imaging. 2003; 29:45-52.
25. Owens CA, Bartolone C, Warner DL, Aizenstein R, Hibblen J, Yaghmai B, et al. The inaccuracy of duplex ultrasonography in predicting patency of transjugular intrahepatic portosystemic shunts. Gastroenterology 1998; 114:975-980.
26. Thalheimer U, Triantos CK, Samonakis DN, Patch D, Burroughs AK. Infection, coagulation and variceal bleeding in cirrhosis. Gut 2005; 54:556-563.
27. Wiest R, Rath HC. Gastrointestinal disorders of the critically ill. Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol 2003; 17:397-425.
28. Aldersley MA, Howdle PD. Intestinal permeability and liver disease. Eur J Gastroenterol Hepatol 1999; 11:401-403.
29. Levine JJ, Pettei MJ, Valderamma E, Gold DM, Kessler BH, Trachtaman H. Nitric oxide and inflammatory bowel disease: evidence for local intestinal production in children with active colonic disease. J Pediatr Gastroenterol Nutr 1998; 26:34-38.
30. Kimura H, Hokari R, Miura S, Shigematsu T, Hirokawa M, Akiba Y, et al. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut 1998; 42:180-187.
31. Rasaratnam B, Kaye D, Jennings G, Dudley F, Chin-Dusting J. The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial. Ann Intern Med 2003; 139:186-193.
32. Ching CK, Allan RN. Polycythemia rubra vera and ulcerative colitis. Am J Gastroenterol 1990; 85:1203-1204.
33. Amitrano L, Guardascione MA, Ames PR, Margaglione M, Antinolfi I, Iannaccone L, .et al. Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease. Am J Hematol 2003; 72:75-81.
34. Collins C, Cahill M, Newland A, Rampton D. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994; 106:840-845.
35. Webberley MJ, Hart MT, Melikian V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut 1993; 34:247-251.